Clinical trial
Reducing Cancer Risk by Training Response Inhibition to Obesogenic Foods
NCT04659837 is registered in ClinicalTrials.gov with Drexel University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Reducing Cancer Risk by Training Response Inhibition to Obesogenic Foods
- Lead sponsor
- Drexel University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 1, 2016
- Completion date
- December 1, 2019
- Enrollment
- 125 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gameifaction, inhibitory control training